Clinical trials
Observational Breast Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
96 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 3 |
| 2009 | 4 |
| 2010 | 6 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 5 |
| 2021 | 9 |
| 2022 | 8 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Unknown status | 28 |
| Recruiting | 15 |
| Not yet recruiting | 3 |
| Enrolling by invitation | 3 |
| Active, not recruiting | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seoul National University Hospital | 19 |
| Samsung Medical Center | 14 |
| AstraZeneca | 8 |
| National Cancer Center, Korea | 7 |
| Severance Hospital | 4 |
| Yonsei University | 4 |
| Gangnam Severance Hospital | 3 |
| Hoffmann-La Roche | 3 |
| Korean Breast Cancer Study Group | 3 |
| Pfizer | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 96 |
| Ovarian Neoplasms | 4 |
| Cystic Fibrosis | 3 |
| Prostatic Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Anxiety Disorders | 2 |
| Colonic Neoplasms | 2 |
| Esophageal Neoplasms | 2 |
| Head and Neck Neoplasms | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.